haematology (other) regimens - comment on existing regimen Please complete this form and submit your comments or amendments Your Details: Your Name: Your Email:   Regimen Details: Haematology (Other) Regimen: Choose One Anagrelide ( v1.0 - Haematology - Chronic Myeloproliferative Disorders) ATG ( v1.0 - Haematology - Myelodysplastic Syndromes) DA 2+5 ( v1.0 - Haematology - Myelodysplastic Syndromes) DA 3 + 10 ( v1.0 - Haematology - Myelodysplastic Syndromes) DA 3 + 8 ( v1.0 - Haematology - Myelodysplastic Syndromes) Eculizimab - Maintenance phase ( v1.0 - Haematology - Paroxysmal Nocturnal Haemoglobinuria) Eculizumab - Initial phase ( v1.0 - Haematology - Paroxysmal Nocturnal Haemoglobinuria) Hydroxycarbamide ( v1.0 - Haematology - Chronic Myeloproliferative Disorders) Low Dose Cytararabine ( v1.0 - Haematology - Myelodysplastic Syndromes) Low Dose Melphalan ( v1.0 - Haematology - Myelodysplastic Syndromes) Rituximab ( v1.0 - Haematology - Thrombocytopenic purpura) Comments:

	Chemotherapy
	Haematology regimens
	Haematology (Other) regimens